PhRMA is a trade group representing pharmaceutical research and biopharmaceutical companies in the US. They work to promote policies that encourage the discovery of new medicines, ensure patient access to safe and effective treatments, protect intellectual property rights, and advocate for transparent regulation. With over 500 new medicines approved since 2000 and over 7,000 medicines in development worldwide, PhRMA's member companies are leaders in medical innovation.